生物技术和生物医学PDF电子书下载

PREFACE 7

Ⅰ．EXECUTIVE SUMMARY 9

Ⅱ．REPORT OF FORUM SESSIONS 15

PART ONE：RESEARCH OPPORTUNITES 15

Session Ⅰ．Areas that Offer Mutual Advantages for Cooperation 15

Session Ⅱ．New Technologies that May Provide Opportunities for Cooperation 19

Session Ⅲ．Biodiversity and Ecology ofInfectious Diseases 24

Session Ⅳ．Clinical Research Systems Compared 29

Session Ⅴ．Differences in Intellectual Property Rights and Bioethics Systems of China and the United States 32

PART TWO：CHALLENGES FOR SCIENTIFIC COOPERATION 36

Session Ⅵ．Discussion of Issues and Differences 36

Rita Colwell Keynote Address 45

Small Group Discussions． 45

Plenary Session． 45

Ⅲ．FORUM PRESENTATIONS 45

Session Ⅰ：Areas that Offer Mutual Advantages for Collaboration 51

YE Xinsheng An overview of funding for biomedical research in China in the Department of Life Sciences，NSFC． 51

QIN Bo Yi Present situation of new drug research in China． 53

HAN Ji-Sheng Acupuncture：from pain relief to treatment of drug addiction． 55

Roger Detels Establishing successful research collaborations 57

Philip Taylor NCI intramural experience in collaborative cancer research in China 58

Session Ⅱ：New Technologies Providing Opportunities for Cooperation 62

WANG Xiaomin Telemedicine in China 62

William Michener Technologies for understanding biocomplexity in the environment 65

CHEN Zhu The human genome project in China 68

Elke Jordan The human genome project in the United States 69

HONG Guofan Rice Genomics—Achievements and Plans． 71

Mary Lou Guerinot Nutritional genomics—manipulating plants to improve human health． 73

JIANG Zhigang Wildlife conservation in China：policy，practice，and prospects． 75

Session Ⅲ．Biodiversity and Ecology of Infectious Diseases 75

ZHU Zuoyan Biodiversity studies in China：progress and opportunities for cooperation 76

Joshua Rosenthal Biodiversity and human health． 77

Jerrold Meinwald The chemistry of biotic interaction． 83

SHAO Yiming Current AIDS research in China and potential for future AIDS vaccine collaboration for China and the United States． 84

Joshua Rosenthal Ecology of infectious diseases． 86

Session Ⅳ：Clinical Research Systems Compared 91

KE Yang Cancer research in China 91

Richard Mowery Organization and management of clinical research at NIH 94

Belinda Seto Clinical trial oversight 95

YU Xiu-Cheng Protection of IPR in China：current situation，problems，and countermeasures 96

Session Ⅴ：Differences in Chinese and U．S．IPR and Bioethics Systems 96

YANG Lin-Cun Intellectual property rights protection of medicine in China 97

Kia Chen Technology transfer at NIH 98

QIAO Yiu-lin Ethical considerations in condicting cancer epidemiological studies in China 105

Eric Meslin＆James Lavery The protection of human subjects：evolution of the U．S．system and efforts to harmonize ethical standards for international research． 107

Ⅳ．FORUM PARTICIPANTS 113

CHINESE TRANSLATION 121

CONTENTS 121

Note：Chinese translation begins on page 121